The following are excerpts from the newsletter

September 8, 2011

  • Telling true stories is an ISMP hallmark Here’s why you should tell stories, too…
  • Lilly updates HumuLIN R U-500 label. The prescribing information for HUMULIN R (insulin regular) U-500 (500 units/mL) was updated recently ( The new label includes information about medication errors and how to prevent them. Mix-ups have occurred in which healthcare providers have picked up and used a U-500 vial of insulin to prepare a dose instead of a U-100 (100 units/mL) vial.
  • Confusion between Plavix and Pradaxa? Our sister organization, ISMP Canada, received three error reports related to the brand names PLAVIX (clopidogrel) and PRADAX (dabigatran etexilate).  In the US, dabigatran is PRADAXA, but we thought we’d alert practitioners since there’s only the letter “a” at the end that’s different.
  • ISMP welcomes three fellows:  Melissa McAuley, PharmD; Stacy Carson, PharmD; Susan Liu, PharmD
  • ISMP webinars...
    • October 27: Pediatric Medication Safety:  The Physician’s and Pharmacist’s Perspectives. Learn why physician-pharmacist collaboration and other key strategies are necessary to support pediatric safety.
    • New Date—December 14: HYDROmorphone: Taking Aim at Events Under the Radar—Regional Initiatives that Show Improvement. Learn how to uncover and reduce “hidden” adverse events with HYDROmorphone. For details, please visit:

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas
  - Free Nursing CEs
Special Alerts
Group Purchasing Subscription
Newsletter Editions
Acute Care
Community/Ambulatory Care
Nurse AdviseERR
Long-Term Care AdviseERR
Safe Medicine
Home | Contact UsEmployment  |   Legal Notices | Privacy Policy | Help Support ISMP
 Med-ERRS | Medication Safety Officer Society Medication Safety Officers Society | Consumer Medication Safety For consumers
ISMP Canada | ISMP Spain  | ISMP Brasil  | International Group  | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved